(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CARDIOVAX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CARDIOVAX

ST13

US500000086796602

Class

5, 42

Filing

86796602

Registration

4977539

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

06/15/2025

Trademark type

Combined

Nice classes

5, 42

Filing date

10/22/2015

Registration date

06/14/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/31/2023

Last transaction

06/15/2025

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

First use anywhere

09/29/2015

First use in commerce

09/29/2015

Drawing code

5

Owner type

16

Owner location

LOS ANGELES, CA

Examiner

ORNDORFF, LINDA

Law office

M20

Current location

TMO LAW OFFICE 111

Mark description

The mark consists of the word "CARDIOVAX" in stylized writing.

Holders and representatives

Holders

ABCENTRA
CardioVax

Representatives

A. Tally Eitan Gornitzky & Co

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medications that are immune therapies for treating cardiovascular and other diseases; vaccines

Class 42

Medicalpharmaceuticalbiotech and clinical research and development of medications that are immune therapies for treating cardiovascular and other diseases

Publications

History of USPTO decisions and trademark events.

15 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/14/2025

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

01/31/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

01/31/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/31/2023

ES8R

TEAS SECTION 8 RECEIVED

07/24/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/14/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/26/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

06/14/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/29/2016

PUBO

PUBLISHED FOR OPPOSITION

03/29/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/09/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/16/2016

DOCK

ASSIGNED TO EXAMINER

02/12/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/27/2015

NWAP

NEW APPLICATION ENTERED

10/26/2015

Continuous trademark protection

Get notified about every new filing that threatens CARDIOVAX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.